916CR 916CR melb

T 000001 000 AHZ

MR SAM SAMPLE FLAT 123

123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030


19March2015
DeaOr ptionholder
NON-RENOUNCEABLEENTITLEMENTOFFER
aI mwritingtoyouinrelationtoyouor ptionholdinginAdmedusLtd( Company()ASX:AHZ).
Asannouncedon18March2015t,heCompanyisundertakinganon-renounceablepro-rata
entitlemenot ffeor nthebasiso1fnewshare( NewShare
f)oer very7sharesheldaat nissue
priceo$f 0.07perNewShare( EntitlementOffer )toraiseupto$16,141,138(beforecosts).
TheEntitlemenOt ffewr ilbl epursuanttoanoffedr ocumen(t
OffeDr ocument ).
InaccordancewiththeListingRulest,heCompanyb, ythisletterg, ivesyounoticeoyf ouright toparticipateintheEntitlemenOt ffers,ubjecttotherequirementsdetailedbelow.
ToparticipateintheEntitlementOffer,youwillneedtohavedexercisedyouroptionsand beenissuedtheresultingsharespriortotherecorddatefortheEntitlementOffer,being
26March2015( RecordDate )N. oticeoef xerciseoof ptionsandpaymenottfheexerciseprice oftheoptionsmustbereceivedbyComputershareInvestorServicesLimitedonorbefore Monday,23March2015.Noticesofexerciseofoptionsreceivedafterthisdatecannotbe assuredotfheallotmenotSf haresbytheRecordDatefotrheEntitlemenOt ffer.
TheEntitlemenOt ffeirsavailabletoAdmedusshareholders( Shareholdersr)egisteredonthe RecordDatewhoseregisteredaddressisinAustraliaorNewZealandaswellascertain professionaland/orsophisticatedShareholderswhoseregisteredaddressisinBelgium,
DenmarkG, ermanyL, uxembourgt,heNetherlandso,trheUnitedKingdom. Iyfourequireanoptionexerciseformp, leasecontacttheCompanyon+61892660100.
TheCompanywildl ispatchtheOfferDocumentoShareholdersotfheCompanyonorabout
30March2015.TheOfferDocumentoutlinestheEntitlementOfferindetail.TheOffer DocumentwillbelodgedwithASXtodayandwillbeavailableontheASXwebsiteat www.asx.com.auandalsoontheCompany'swebsiteawt ww.admedus.com.

TheEntitlemenOt ffeirsnobt eingunderwritten.

Samples/000001/000001


TheindicativetimetablefotrheEntitlemenOt ffeirsasfollows:
Event Date
AnnouncemenotOf ffear ndPlacement
Wednesday1, 8March2015
LodgemenotAf ppendix3BandCleansingStatement
Wednesday1, 8March2015
Dispatchnoticeorfightsissuetoshareholdersand optionholders
Thursday1, 9March2015
LodgemenotOf ffeDr ocument Friday2, 0March2015
RightsissueExDate
Tuesday2, 4March2015
SettlemenotSf haresundetrhePlacement Tuesday2, 4March2015
IssueoSf haresundetrhePlacement
Wednesday2, 5March2015
RecordDate(datefodr eterminingentitlementsoEf ligible
ShareholderstoparticipateintheOffer)
Thursday2, 6March2015
OffeDr ocumenat ndEntitlemenat ndShortfaFll orms dispatchedtoEligibleShareholders
Monday3, 0March2015
RightsissueoffeOr peningDate Monday3, 0March2015
Lasdt aytonotifyASXoaf nyextensiontotheRightsissue
ClosingDate
Wednesday8A, pri2l 015
RightsissueClosingDate*
Tuesday1, 4Apri2l 015
RightsissueSharesquotedonadeferredsettlemenbt asis Wednesday1, 5Apri2l 015
CompanytonotifyASXouf ndesrubscriptions(iaf ny) Thursday1, 6Apri2l 015
RightsissueandShortfalSl hares*i*ssued Monday2, 0Apri2l 015
DispatchholdingstatementsfoRr ightsissueandShortfall
Shares**
Tuesday2, 1Apri2l 015

ThistimetableisindicativeonlyandmaybesubjecttochangeT. heCompanyreservestherightto
amendthisindicativetimetableaat nytimes,ubjec
ttotheCorporationsAcat ndtheListingRules.
S* ubjecttotheListingRulest,heDirectorsreservetherighttoextendtheClosingDatefotrhe Offearttheidr iscretionS. houldthisoccurt,heextensionwilhl aveaconsequentiael ffecot nthe anticipate dateoifssuefotrheNewShares.
*S* hortfalol ffeirsubjecttoEligibleShareholdersnottakingupaloltfheirrightstoNewShares undetrheOffer.

UseoFf unds
CompletionotfheOffear ndPlacemenwt ilrlais eapproximately$28M(beforecosts)a, ssuming thant oOptionsareexercisedpriotrotheRecordDate.
ThefundsraisedfromtheOffear reproposedtobeexpendedasfollows:

Description

Approximate

$

Ongoingsalesteambuildandsupport

$9M

CardioCelc®ardiovasculaer xpansionstudies

$3M

Expansionorfegenerativetissueportfolio

$3.5M

Additionarlegulatoryfilings

$1M

Tissuemanufacturingscaleupandprocessdevelopment

$2M

HPVPhaseI/IpI reparationandstudyplusmanufacturing 1

$3.5M

AdditionailmmunotherapyR&D 1

$2M

Providefurthewr orkingcapital

$2.5M

CosottfheOffer

$1.5M

TotaflundsraisedundetrheOffer

$28M

F1 urtheirnvestmenitntothetherapeuticvaccines
ShortfalOl ffer
IntheeventthattheOffeirsnoftullysubscribedt,hedirectorsreservetherights, ubjecttoany

restrictionsimposedbythe

CorporationsAct2001(Cth)

andListingRules,toissueshortfall

sharesattheisrolediscretion(

ShortfalOl ffer ).

TheShortfalOl ffeirsaseparateoffemr
adepursuanttotheOffeDr ocumenat ndmayremain
openaftetrheClosingDateT. heissuepriceotfheshortfalslhareswilbl e$0.07eachb, eingthe samepriceastheNewSharesbeingofferedundetrheOffer.
NoAdjustmentstoOptionExercisePrices
Undetrhetermsoyf ouor ptionstherewilbl enoadj ustmenttotheexercisepriceoyfouor ptions duetotheEntitlemenOt ffer.

Samples/000001/000002/i12


OverseasShareholders
TheoffermadeundertheOfferDocumenat ndanyaccompanyingformdoesnota, ndisnot intendedto,constituteanofferofsecuritiesinanyplaceorjurisdictioninwhich,ortoany persontowhomiw,t ouldnobt elawfutlomakesuchanoffeor troissuetheOffeDr ocumenot r theNewSharesundetrheEntitlemenOt ffeAr.seftorthintheOffeDr ocumentt,hedistribution otfheOfferDocumenitnjurisdictionsoutsideAustraliaandNewZealandisrestrictedbylaw andpersonswhocomeintopossessionotfheOffeDr ocumensthouldobservesuchrestrictions. Anyfailuretocomplywithsuchrestrictionsmayconstituteaviolationoaf pplicablesecurities laws.
ShouldyouhaveanyqueriesinrelationtotheEntitlementOffer,pleasedonothesitateto contacttheCompanyon+61892660100.

Yoursincerely
StephenMann
CompanySecretary

distributed by